Form D · Pharmaceuticals
LUCIER PHARMACEUTICALS INC
Bryan, TX · CIK 0002158290
Offering snapshot reported Oct 13, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2026 | Initial | Yet to sell | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601034
Expect to close this round by 2/28/2027.
SAFE (Simple Agreement for Future Equity), which does not grant immediate equity or voting rights.
Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guangrong Lu Lu | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3608 E. 29th Street Suite 209
Bryan, TX, 77802
Bryan, TX, 77802